Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
About Investor
Rob Hopfner serves as Managing Director and Partner at Pivotal bioVenture Partners, focusing on investments in Pharmaceuticals and BioTech sectors at seed, Series A, and Series B stages with investment ranges between $100K and $5.0M. Hopfner previously worked as Managing Director at Bay Capital and leads a $300 million life sciences venture capital fund established in 2017 that invests in privately held North American biotechnology companies from the San Francisco Bay Area.
Previous investments
Evommune
120M |2024
50M |2023
83M |2021
13M |2020
Oculis
57M |2021
21M |2018
Plexium
100M |2022
35M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP